Year-end results published by Rosemount

Rosemount Pharmaceutical announced profits of £8.3 million in its Directors Report for the year ending December 31st 2007 – up from £6 million the year before. The firm remains confident in its “healthy stream of new products”, which it envisages will contribute to continued growth according to a company statement.